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Oxygen pressureUrate oxidase from Aspergillus ﬂavus is a 135 kDa homo-tetramer which has a hydrophobic cavity
buried within each monomer and located close to its active site. Crystallographic studies under
moderate gas pressure and high hydrostatic pressure have shown that both gas presence and high
pressure would rigidify the cavity leading to an inhibition of the catalytic activity. Analysis of the
cavity volume variations and functional modiﬁcations suggest that the ﬂexibility of the cavity would
be an essential parameter for the active site efﬁciency. This cavity would act as a connecting vessel
to give ﬂexibility to the neighboring active site, and its expansion under pure oxygen pressure
reveals that it might serve as a transient reservoir on its pathway to the active site.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Urate oxidase (uricase; EC 1.7.3.3; UOX) is a tetrameric enzyme
belonging to the purine degradation pathway which catalyzes the
oxidation of uric acid (1) to a metastable intermediate, 5-hydroxy-
isourate (5-HIU) (2). The reaction needs molecular oxygen and
releases hydrogen peroxide. 5-HIU is further transformed to
S-allantoin (3) through a catalytic cascade.The exact catalytic mechanism is still not fully understood,
there is no cofactor nor metallic ion, the optimal pH is basic (be-
tween 8.5 and 9), and it is known for a long time that the oxygen
atoms in H2O2 derive from those of O2 [1–5].
UOX from Aspergillus ﬂavus in presence of a competitive inhib-
itor like 8-azaxanthine crystallizes in the orthorhombic space
group I222 with one monomer of 301 residues per subunit. Thefunctional homotetrameric enzyme is built around the 2-fold crys-
tallographic axes. The active site is located at the interface between
two subunits folded around a tunnel. 8-azaxanthine is locked in
the active site by a Arg 176-Gln 228 molecular tweezers [6,7].
The peroxohole located above the active site is usually ﬁlled by
a catalytic water molecule W1 hydrogen-bounded to the side
Table 1
Data collection and reﬁnement statistics.
Native O2 4 MPa
PDB entry 4OP9 4OP6
Parameters (Å)
a 80.11 79.92
b 96.18 96.17
c 105.41 105.40
Resolution (Å) 1.60 1.65
Completeness (%) 98.8 (95.6) 100 (100)
Redundancy 5 (4.6) 5 (5)
Unique reﬂections 55375 (2674) 49104 (2417)
Rsym⁄ 4.2 (36.4) 4.4 (37.3)
I/r (I) 33.4 (2.9) 33.6 (3.4)
Rwork⁄ 16.78 16.46
Rfree⁄ 19.06 18.85
Mean B factor (Å2) 22.78 22.62
r.m.s. ideality
Length (Å) 0.009 0.009
Angle () 1.342 1.361
Data between parentheses correspond to the highest resolution shell.
⁄Rsym =
P
h,k,l
P
i|Ii(h,k,l)  hIi(h,k,l)i|/Ph,k,l Pi Ii(h,k,l), where Ii(h,k,l) is the
intensity of observed reﬂections and <Ii (h,k,l)> the weighted mean of all observa-
tions after rejection of outliers. §Rwork =
P
|Fo|  |Fc|/P|Fo|; indicates accuracy of
the model. #Rfree is a cross validation residual using 5% of the native data which
were randomly chosen and excluded from the reﬁnement.
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crystals are soaked in NaCl or in cyanide solution, the peroxohole
exchanges this water molecule for a chloride ion or a cyanide [8,9].
A large internal cavity completely buried inside each monomer
is located very close to the active site, with the residue Val 227 in
frontier between the active site and the cavity. Indeed, Val 227 side
chain lines the internal cavity while its main chain nitrogen is
hydrogen-bonded to the ligand (either the inhibitor 8-azaxantine
or the natural substrate uric acid). This internal cavity is void,
meaning that no water can be seen in the electron density map.
It is very hydrophobic, lined with almost 90% of carbon atoms. It
is well known that internal cavities within proteins are crucial
for conformational ﬂexibility and domain motion [10,11] and
accessibility for small ligands can only be granted through thermal
motion [12]. Flexibility is thought to be necessary for functional
efﬁciency.
To unravel the functional relevance of UOX internal cavity, we
used a structural approach combining crystallography at room
temperature under moderate anesthetic gas pressure and under
high hydrostatic pressure. These two complementary approaches
allow to determine the most ﬂexible part of the protein in relation
with internal cavity modiﬁcations. Indeed, the analysis of protein
structures determined under moderate inert gas pressure have re-
vealed that the main gas-induced structural modiﬁcations occur on
the volume of cavities which bind the inert gas, their volumes
expanding with the applied gas pressure [13,14]. On the other
hand, the analysis of protein structures determined under high
hydrostatic pressure have revealed that the main pressure-induced
structural effects occur on the volumes of cavities which are re-
duced [15,16]. Activity assays in presence of inert gas and under
high hydrostatic pressure have also been performed on UOX to
establish the biological signiﬁcance of these crystallographic ﬁnd-
ings. We also used crystallography under dioxygen pressure in or-
der to visualize the oxygen binding site.
2. Methods
2.1. Crystallization and data collections
Puriﬁed recombinant UOX from A. ﬂavus, expressed in Saccharo-
myces cerevisiae, was a gift from Sanoﬁ-Aventis (Montpellier,
France). UOX crystals were grown either by batch and hanging-
drop methods using a 10–15 mg/ml solution of UOX, with an ex-
cess of 8-azaxanthine (purchased from Sigma–Aldrich, Lyon,
France), in 50 mM Tris/acetate (pH 8) in the presence of 5–8%
PEG 8000. This led to crystal in space group I222 with 1 monomer
per asymmetric unit [7].
Crystallography under Xe and N2O pressure and activity assays
in presence of gas have been described in [17]. Crystallography un-
der O2 pressure has been described in [8] and uses the same exper-
imental devices. Crystallography under high hydrostatic pressure
and activity assays under high pressure have been described in
[18]. All diffraction data (gas-less, under pressurized gas, ambient
pressure and high hydrostatic pressure) have been collected at
room temperature.
Diffraction data for two additional structures of UOX in complex
with 8-azaxanthin, gas-less and under 4 MPa of dioxygen, were
collected at room temperature at the BM14 beamline at the
European Synchrotron Radiation facility (ESRF, Grenoble, France).
Detector used was a MAR CCD detector. Data were indexed and
integrated by DENZO and scaled independently and reduced using
SCALEPACK, both programs from the HKL package [19]. Intensities
were converted in structure factor amplitudes using TRUNCATE
and structure reﬁnements were carried out using REFMAC [20],
all from the CCP4 package [21]. PDB entry 2IBA in whichheteroatoms and alternate side-chain positions were removed
was used as starting model for rigid body reﬁnement. The graphics
program COOT [22] was used to visualize electron density maps
and for manual rebuilding. A summary of the X-ray data collection
and reﬁnement statistics is given in Table 1. Atomic coordinates
and structure factors have been deposited at the PDB (entry code
4OP9 for gas-less UOX and 4OP6 for UOX under 4 MPa oxygen).
2.2. Cavity volumes calculations
Several programs are available for that purpose, they give
slightly different results as the method is very sensitive to the geo-
metric parameters but whatever the program in use, accurate com-
parative results are obtained as long as the same protocol is used
throughout. In the present study, calculations of cavities volume
were performed using CASTp with a sphere radius of 1.4 Å [23],
and VOIDOO [24] with the parameters as described in [25]: primary
grid spacing of 0.6 Å, grid spacing of 0.6 Å, and probe radius of 1 Å.
The cavities volume in the different structures are given in Table 2.
Room mean squares deviations (rmsd’s) derived from bond
lengths, angles, and chiral volumes rmsd’s obtained from X-ray
structures were found in all cases within the range 5–8% of the
calculated volumes. Figures were prepared using PYMOL (DeLano
Scientiﬁc, CA, USA).
3. Results
3.1. Crystallography and activity assays under inert gas pressure
Metabolically inert gases like Xe or N2O were bound within the
internal void cavity of UOX located close to the active site.
The main structural modiﬁcation in UOX-gas complexes was the
expansion of the volume of the cavity, which increased with the
applied pressure (Fig. 1A). The volume of the internal cavity in
the gas-less UOX structure expanded with the presence of gas.
The expansion induced by the mixture Xe:N2O was greater than
the expansion induced by Xe alone, itself greater than the expan-
sion induced by N2O alone (Table 2). In parallel, activity assays per-
formed in presence of air, Xe, N2O and Xe:N2O in physiological
conditions showed that the presence of gas within the internal
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induced by the mixture Xe:N2O was greater than the inhibition in-
duced by Xe alone, itself greater than the inhibition induced by
N2O alone. The correlation between gas-induced structural modiﬁ-
cations and gas-induced functional modiﬁcations suggested that
the cavity has a functional role in the catalytic mechanism of
UOX [17].
3.2. Crystallography and activity assays under high hydrostatic
pressure
The main structural difference between the crystallographic
structures of UOX at 140 or 150 MPa compared to ambient pres-
sure structure was, as expected, the diminution of the volume of
the internal cavity (Table 2). Interestingly, the volume of the near-
by active site located between two monomers was enlarged by
pressure (Fig. 1B). In parallel, activity assays have been performed
under pressure. Pressure induced an inhibition of the enzymatic
activity of UOX which occurred before the enzyme loose its solubil-
ity, meaning that the enzyme was still folded but less active under
pressure up to 200 MPa. Above 200 MPa, the protein was then
progressively unfolded. The reduction of the cavity volume by
pressure in parallel to the increase of the active site volume sug-
gested that the cavity could act as a connecting vessel during the
catalytic mechanism [18].
3.3. Crystallography under dioxygen pressure
When using dioxygen under pressure, the gas molecule was ob-
served bound in the active site above the 8-azaxanthine inhibitor
[8]. It took the place of the catalytic water molecule W1 in the per-
oxohole, also interacting with the side chains of Asn 254 and Thr
57⁄ (Fig. 2). When looking at the hydrophobic cavity, no density
was visible in the electron density map. However, the volume of
the cavity expanded in presence of oxygen (Table 2). This result
indicated that, even if no dioxygen molecule was structurally or-
dered (visible) within the cavity, it would expand its volume. These
ﬁndings suggested that the cavity might act a transient reservoir
for oxygen on its way to the nearby active site.4. Discussion
In urate oxidase, the internal cavity’s volume is modiﬁed by
pressure and gas presence (Xe, N2O, XeN2O and O2). This modiﬁca-
tion of volume arises from small perturbations in the residues lin-
ing the cavity. To correlate the cavity expansion/reduction and
dynamics, we analyzed the isotropic thermal factors of atoms
lining the cavity. The average B-factors of the residues lining the
cavity and the active site are lower by 4 Å2 and by 3 Å2 respec-
tively, compared to the overall <B> factors, whatever the analyzed
structure (native, high hydrostatic pressure, under Xe, N2O, XeN2O
or O2 pressure). Hydrostatic pressure increases the <B> factors by
5 Å2, with a similar increase of <B> factors in residues lining
the cavity or the active site. The proposed rigidity of the cavity in-
duced by high pressure or gas presence has thus no real incidence
on the B-factors of the residues lining it. The modiﬁcations of cav-
ity’s volumes induced by pressure or gas presence are small, nev-
ertheless they can be considered as meaningful since on one
hand they are consistent with external experimental constraints
(decreased by pressure and increased with the applied gas pres-
sure) and on the other hand the differences compared to the
volume in gas-less urate oxidase at ambient pressure are above
the estimated error on volumes (5–8%). The hydrostatic pressure
reduces the volume, as estimated by CASTp, by 10–20%; gases
which bind within the cavity like Xe or N2O increased the volume
Q 228
V 227
8-azaxanthine
Q 228
V 227
8-azaxanthine
Xe
High pressure
A B
Fig. 1. (A) Active site and its neighboring hydrophobic cavity under 3 MPa of xenon (represented as mesh volumes). Xenon atom is represented by an orange sphere and
induces an expansion of the volume of the cavity (represented by arrows). (B) Same representation of the UOX active site and cavity under high hydrostatic pressure. This
induces a contraction of the volume of the internal void cavity and an expansion of the volume of the active site located at the interface between two subunits (represented by
arrows). The two frontier residues Val 227 and Gln 228 are represented in stick, colored by atom type.
1718 N. Colloc’h, T. Prangé / FEBS Letters 588 (2014) 1715–1719by 40–50%, and gas like O2 which would be transient in the cavity
increased its volume by 30%.
The structural and functional results presented here highlight
that the internal cavity in UOX would play a key role in the enzy-
matic function. Gas like Xe or N2O which binds within the nearby
cavity induces an expansion of the cavity that inhibits the catalytic
mechanism of UOX. On the other hand, high hydrostatic pressure
induces a contraction of the cavity and inhibits the catalytic mech-
anism of UOX. Both gas presence and hydrostatic pressure seems
to disrupt the cavity ﬂexibility and increase its rigidity. These re-
sults suggest that the cavity rigidity could hamper the active site
plasticity, suggesting that, like the active site ﬂexibility, the inter-
nal cavity ﬂexibility would be crucial for UOX catalytic activity. The
substrate uric acid is ﬂat while the product 5-hydroxyisourate and
the intermediate 5-hydroxyperoxoisourate have a larger volume.
Thus, the active site needs to expand to accommodate these larger
intermediates, a mechanism likely to be hampered when the cavity
becomes more rigid.
Proteins possess many conformational sub-states and proteins
motions can be described as discrete transitions between numerous
conformational sub-states [26,27]. In enzymes, the balance
between conformational ﬂexibility and rigidity is adjusted to
optimize the catalytic efﬁciency [28,29]. Energy landscapes of pro-
tein can be probed by pressure through the modiﬁcation of the
Gibbs free energy. The pressure modiﬁes the populations of con-
formers and promote high energy conformers thus allowing the
exploration of functional pathways [15,30–34]. Cavities introduce
adaptive features that facilitate conformational transitions and are
thus thought to play a key role in protein function [35]. In globins
for example, cavities are involved in migration pathways for O2
and CO [36–38]. Mutations that reduce internal cavity volume in-
crease protein stability [39,40]. Anesthetic binding to proteinswith-
in internal cavities also leads to an increase in protein stability and
further shifts the population of conformational sub-states [41–44].
Pressure can also induce a stabilization through a compression of
hydrophobic cavities resulting in increased van der WaalsT 57*
N 254
F 159
R 176
Q 228
V 227
8-azaxanthine
O2
Fig. 2. Electron omit map of the active site of urate oxidase under 4 MPa of
dixoygen pressure showing the O2 molecule in the peroxohole. Residues involved in
the catalytic activities are shown in stick, colored by atom type.contacts and shifts conformational sub-states [45,46]. Internal cav-
ities play thus a fundamental role in sampling the different confor-
mational sub-states. The present study experimentally illustrates
the relationships between local rigidity and overall ﬂexibility, sug-
gesting that UOX cavity would be deeply involved in the protein
activity.
Our results also support for the internal cavity of UOX a puta-
tive role of a transient docking pathway for dioxygen, since the
cavity volume expands in presence of dioxygen. Xenon, which
has often been used to probe dioxygen transient pathway, binds
within this cavity. For example, in globin and in enzymes, xenon
binding sites in cavities map small gaseous ligands transient path-
way [38,47–54]. In UOX, the internal cavity where xenon binds is
very close to the active site and can have the same function as in
globin for dioxygen.
In conclusion, structural and functional analyses of urate oxi-
dase in complex with 8-azaxanthine under inert gas pressure, un-
der dioxygen pressure and under high hydrostatic pressure have
suggested a functional relevance of this cavity in the catalytic
mechanism. The cavity could be considered as an allosteric site act-
ing as a connecting vessel to give ﬂexibility to the active site, and
also as a transient storage place for dioxygen on its way to the
peroxohole.
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